flatiron-health
(2)
Josh Haimson
Josh Haimson is the co-founder and CEO of Inductive Bio, a New York based AI company building software to speed up small molecule drug discovery. Before starting Inductive in 2024 with Ben Birnbaum, Josh ran product for the machine learning and data curation teams at Flatiron Health, generating real-world evidence across a network of more than 2 million cancer patients. The company raised a $25M Series A in May 2025 led by Obvious Ventures, and its Compass platform helps chemists predict a molecule's ADMET properties before it is ever synthesized, attacking the 'whack-a-mole' bottleneck that slows drug development.
Ogi Kavazovic
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.